January 10, 2013
Satoshi Ueki, Director, Cardiovascular, Ethical Products Marketing Department, Pharmaceutical Marketing Division, Takeda Takeda Pharmaceutical’s hyperlipidemia treatment Lotriga (omega-3-acid ethyl esters) hit pharmacy shelves on January 10, marking the firm’s foray into the market of omega-3 fatty acid products, which contain...read more